Comerica Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Comerica Bank’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,500	Closed	-$4.48K	–	3758
2024 Q2	$4.48K	Sell	12,500 -12,500	-50%	-$6.75K	﹤0.01%	3324
2024 Q1	$16.8K	Hold	25,000	–	–	﹤0.01%	3078
2023 Q4	$13.6K	Hold	25,000	–	–	﹤0.01%	3079
2023 Q3	$15K	Buy	+25,000	New	+$26.8K	﹤0.01%	3085
2022 Q4	$45K	Hold	12,500	–	–	﹤0.01%	2116
2022 Q3	$54K	Hold	12,500	–	–	﹤0.01%	2108
2022 Q2	$59K	Hold	12,500	–	–	﹤0.01%	2135
2022 Q1	$64K	Hold	12,500	–	–	﹤0.01%	2144
2021 Q4	$75K	Hold	12,500	–	–	﹤0.01%	2134
2021 Q3	$104K	Sell	12,500 -3,233	-21%	-$32K	﹤0.01%	2177
2021 Q2	$142K	Sell	15,733 -428	-3%	-$4.85K	﹤0.01%	2286
2021 Q1	$189K	Sell	16,161 -397	-2%	-$5.35K	﹤0.01%	2263
2020 Q4	$248K	Hold	16,558	–	–	﹤0.01%	2186
2020 Q3	$180K	Hold	16,558	–	–	﹤0.01%	2206
2020 Q2	$184K	Hold	16,558	–	–	﹤0.01%	2167
2020 Q1	$138K	Buy	16,558 +410	+3%	+$3.04K	﹤0.01%	2135
2019 Q4	$116K	Hold	16,148	–	–	﹤0.01%	2233
2019 Q3	$140K	Buy	16,148 +244	+2%	+$2.74K	﹤0.01%	2210
2019 Q2	$188K	Hold	15,904	–	–	﹤0.01%	2200
2019 Q1	$198K	Hold	15,904	–	–	﹤0.01%	2188
2018 Q4	$177K	Sell	15,904 -34	-0.2%	-$422	﹤0.01%	2177
2018 Q3	$214K	Hold	15,938	–	–	﹤0.01%	2163
2018 Q2	$241K	Buy	15,938 +529	+3%	+$8.79K	﹤0.01%	2144
2018 Q1	$296K	Sell	15,409 -88	-0.6%	-$1.88K	﹤0.01%	2073
2017 Q4	$311K	Hold	15,497	–	–	﹤0.01%	2074
2017 Q3	$196K	Buy	15,497 +527	+4%	+$5.83K	﹤0.01%	2181
2017 Q2	$141K	Hold	14,970	–	–	﹤0.01%	2139
2017 Q1	$73K	Hold	14,970	–	–	﹤0.01%	2178
2016 Q4	$66K	Buy	14,970 +2,412	+19%	+$8.78K	﹤0.01%	2165
2016 Q3	$54K	Hold	12,558	–	–	﹤0.01%	2081
2016 Q2	$62K	Hold	12,558	–	–	﹤0.01%	2068
2016 Q1	$86K	Hold	12,558	–	–	﹤0.01%	2053
2015 Q4	$93K	Sell	12,558 -271	-2%	-$2.09K	﹤0.01%	2029
2015 Q3	$72K	Sell	12,829 -12,829	-50%	-$106K	﹤0.01%	2020
2015 Q2	$286K	Buy	25,658 +12,829	+100%	+$165K	﹤0.01%	2018
2015 Q1	$201K	Sell	12,829 -12,909	-50%	-$200K	﹤0.01%	1972
2014 Q4	$392K	Buy	25,738 +12,869	+100%	+$156K	﹤0.01%	1991
2014 Q3	$139K	Sell	12,869 -909	-7%	-$11.9K	﹤0.01%	2047
2014 Q2	$211K	Sell	13,778 -4,337	-24%	-$62.4K	﹤0.01%	2032
2014 Q1	$328K	Sell	18,115 -73	-0.4%	-$1.41K	﹤0.01%	2011
2013 Q4	$253K	Sell	18,188 -11,756	-39%	-$135K	﹤0.01%	2076
2013 Q3	$314K	Hold	29,944	–	–	﹤0.01%	2219
2013 Q2	$234K	Buy	+29,944	New	+$261K	﹤0.01%	2053

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Comerica Bank's SGMO Position: Q3 2024 in Review

Comerica Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 12,500 shares — an estimated $4.48K sold.

Comerica Bank first reported a position in SGMO in Q2 2013 and held it in 43 quarters. The position peaked at $392K in Q4 2014. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

Comerica Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
Comerica Bank sold 12,500 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $4.48K.
Comerica Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 43 quarters.
Comerica Bank's SANGAMO THERAPEUTICS INC position peaked at $392K in Q4 2014.
103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.